Image for rAd5-SARS-CoV-2-S

rAd5-SARS-CoV-2-S

rAd5-SARS-CoV-2-S is a COVID-19 vaccine developed using a harmless adenovirus (a common cold virus) modified to carry the gene for the spike protein of the virus that causes COVID-19. When administered, it prompts the immune system to recognize and respond to the spike protein, preparing the body to fight the actual virus if encountered later. This vaccine uses viral vector technology to safely stimulate immunity without causing disease, contributing to protection against COVID-19.